THE PRESENT INVENTION IS RELATED TO A NOVEL USE OF A LANOSTANE HAVING THE FOLLOWING FORMULA (I) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN TREATING A DISEASE INDUCED FROM IMMUNE DISORDER: WHEREIN R1 IS EITHER H OR CH3; R2 IS OCOCH3, =O OR OH; R3 IS H OR OH; R4 IS -C(=CH2)-C(CH3)2Ra, IN WHICH Ra IS H OR OH, OR -CH=C(CH3)-Rb, IN WHICH Rb IS CH3 OR CH2OH; R5 IS H OR OH; AND R6 IS CH3 OR CH2OH.